AZO
48
3
MMM
28
-2
F
40
5
FDX
30
-9
CAH
44
-6
AA
43
2
MAT
62
2
COF
57
-2
GLW
48
-4
WBA
48
-2
CNP
44
8
CFG
52
-2
WEC
41
-4
NI
60
2
RSG
60
3
DAL
77
-3
NAVI
43
16
CMA
50
-2
VFC
65
2
OKE
65
4
AZO
48
3
MMM
28
-2
F
40
5
FDX
30
-9
CAH
44
-6
AA
43
2
MAT
62
2
COF
57
-2
GLW
48
-4
WBA
48
-2
CNP
44
8
CFG
52
-2
WEC
41
-4
NI
60
2
RSG
60
3
DAL
77
-3
NAVI
43
16
CMA
50
-2
VFC
65
2
OKE
65
4
Financhill
Back

Viking Therapeutics 10K Form

Sell
45

VKTX
Viking Therapeutics

Last Price:
63.15
Seasonality Move:
38.04%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive VKTX News And Ratings

See the #1 stock for the next 7 days that we like better than VKTX

VKTX Financial Statistics

Sales & Book Value

Annual Sales: --
Cash Flow: $-21.96M
Price / Cash Flow: 0
Annual Sales: $8.18
Price / Book: 7.72

Profitability

EPS (TTM): -0.93000
Net Income (TTM): $-99.15M
Gross Margin: $0
Return on Equity: 0%
Return on Assets: 0%

Viking Therapeutics Earnings Forecast

Key Viking Therapeutics Financial Ratios

  • The Interest Expense is 0.00% of Operating Income.
  • Per Share Earnings over the last 11 years have been positive in 5 years.

Viking Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: VKTX
CUSIP: 92686J
Website: vikingtherapeutics.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

VKTX Technical Analysis vs Fundamental Analysis

Sell
45
Viking Therapeutics (VKTX) is a Sell

Is Viking Therapeutics a Buy or a Sell?